This study suggests that treating obesity by increasing energy expenditure as a result of brown adipose thermogenesis is more likely to be successful by combined drug therapy aimed at stimulating both PKA and PPARγ signalling pathways. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.